Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study tests metformin to stop diabetes in breast cancer survivors

NCT ID NCT06763328

First seen Jan 31, 2026 · Last updated Apr 30, 2026 · Updated 9 times

Summary

This study looks at whether the diabetes drug metformin can help prevent or reverse insulin resistance (a step toward diabetes) in women who have finished chemotherapy for early-stage breast cancer. About 200 women will be randomly assigned to receive either metformin plus standard diet and exercise advice, or standard advice alone. The goal is to see if metformin can keep blood sugar levels healthy and reduce the risk of diabetes and heart disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANATOMIC STAGE III BREAST CANCER AJCC V8 are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • City of Hope Medical Center

    RECRUITING

    Duarte, California, 91010, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • UC San Diego Moores Cancer Center

    NOT_YET_RECRUITING

    La Jolla, California, 92093, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of California-Riverside

    NOT_YET_RECRUITING

    Riverside, California, 92521, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.